Yaw C. Lim

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.

A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 31, 2026

Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers.

Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers.

Journal: NPJ precision oncology

Published: October 17, 2025

Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations.

Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations.

Journal: Cell proliferation

Published: March 13, 2024

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.

Journal: The Journal of clinical investigation

Published: March 03, 2023

FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.

FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.

Journal: Theranostics

Published: February 22, 2022

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.

Journal: Molecules (Basel, Switzerland)

Published: September 29, 2020

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 08, 2020

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.

Journal: Nature communications

Published: May 19, 2019

Circulating Microparticle Double-Stranded Deoxyribonucleic Acid in Systemic Lupus Erythematosus.

Circulating Microparticle Double-Stranded Deoxyribonucleic Acid in Systemic Lupus Erythematosus.

Journal: Annals of the Academy of Medicine, Singapore

Published: September 30, 2016

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.

Journal: Oncotarget

Published: August 26, 2014

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma.

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: June 27, 2014

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.

Journal: Cancer discovery

Published: July 27, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026